COMMUNIQUÉS West-GlobeNewswire

Abeona Management to Present at Multiple Conferences in November
13/11/2017
NEW YORK and CLEVELAND, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017
13/11/2017
DOYLESTOWN, Pennsylvania, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ) today reported its financial results for the three months and nine months ended September 30, 2017 [...]
EHNAC Congratulates PokitDok on Achieving HITRUST CSF™ Certification
13/11/2017
FARMINGTON, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body for organizations that [...]
Assure Holdings Performs First Neuromonitoring Case in Texas
13/11/2017
PARKER, Colo., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSX-V: IOM ) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, has performed its first [...]
International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial
13/11/2017
CARLSBAD, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products [...]
Cidara Therapeutics Named a San Diego Metro Area 2017 Top Workplace
13/11/2017
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has been named a 2017 [...]
Combination Immunotherapy of Pembrolizumab with the Galectin-3 Inhibitor GR-MD-02 Shows Promising Early Results in Treatment of Advanced Melanoma from a Phase 1b Clinical Trial
13/11/2017
NORCROSS, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, and Providence Cancer Institute today announced the [...]
BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance
13/11/2017
BERKELEY, Calif. and VANCOUVER, British Columbia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company [...]
SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update
13/11/2017
SAN RAMON, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]
80% of Prostate Cancer Patients in OncBioMune Phase 1 Clinical Trial of ProscaVax Show No Disease Progression at the First Post-Therapy Follow-up
13/11/2017
BATON ROUGE, La., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary [...]
Peregrine Announces Date of 2017 Annual Meeting of Stockholders
13/11/2017
TUSTIN, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ) today announced that its 2017 Annual Meeting of Stockholders will be held on January 18, 2018, at 14191 [...]
Nexstim gains FDA clearance to commercialise its NBT® system in the US for the treatment of depression
13/11/2017
C ompany announcement, Helsinki, 13 November 2017 at 3 pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]
Medtronic to Present New Clinical Data on Vascular Interventions and Key Symposia at VEITHsymposium 2017
13/11/2017
DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular embolization therapies at the 44 [...]
Fibrocell Reports Third Quarter 2017 Financial Results and Recent Highlights
13/11/2017
EXTON, Pa., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Immune Design to Present at Jefferies 2017 London Healthcare Conference
13/11/2017
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), a clinical-stage immunotherapy company focused on cancer, today announced that Carlos Paya, M.D., Ph.D., [...]
Tyme to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
13/11/2017
NEW YORK, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Tyme Inc. (Nasdaq: TYME ), a biotechnology company using cellular metabolism and oxidative stress to develop cancer therapeutics, today announced that Jonathan Eckard, Chief [...]
Global Blood Therapeutics Announces Completion of Safety Review by Independent Data and Safety Monitoring Board (DSMB) for Phase 3 HOPE Study in Sickle Cell Disease
13/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) announced today that the independent Data and Safety Monitoring Board (DSMB) for the Phase 3 HOPE ( H [...]
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™
13/11/2017
At-home collection, one-day fecal immunochemical test that meets American Cancer Society guidelines and HEDIS quality measures for lower gastrointestinal bleeding screening programs A number of medical conditions may be [...]
Intra-Cellular Therapies Expands Its Executive Team with the Appointment of Dr. Andrew Satlin as Executive Vice President and Chief Medical Officer
13/11/2017
NEW YORK, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]

Pages